Pharmaceutical Technology

NOVEMBER 30, 2022

“Bariatric surgeries show 30% weight loss in the first year and 25% weight loss in the long term,” says Papamargaritis, while that the clinical data for Mounjaro shows that the drug leads to a 16–22.5% Novo Nordisk is another company leading the charge in this field. weight loss in obese or overweight individuals.

Medical 105

Medical Manufacturing Insurance Side effects 105

Clarivate

JULY 16, 2019

Customer experience has been growing rapidly in the last few years because it is one of the most significant ways to differentiate your brand in this increasingly competitive market. Here are some CX statistics that we have gathered and should get the attention of your CEO and CFO, and lead to further CX progress for your company. .

Competition 40

Competition Sales Leads Marketing 40

Pharmaceutical Technology

NOVEMBER 30, 2022

“Bariatric surgeries show 30% weight loss in the first year and 25% weight loss in the long term,” says Papamargaritis, while that the clinical data for Mounjaro shows that the drug leads to a 16–22.5% Novo Nordisk is another company leading the charge in this field. weight loss in obese or overweight individuals.

Medical 98

Medical Manufacturing Insurance Side effects 98

Pharmaceutical Technology

JANUARY 10, 2023

Type 2 diabetes (T2D) is a crowded and competitive landscape with multiple “me-too,” generic and biosimilar drugs entering the market, with market growth primarily driven by an increasing prevalent population across nine major markets (9MM: US, France, Germany, Italy, Spain, UK, Japan, China, and India).

Marketing 52

Marketing Physicians Sales Leads 52

Clarivate

APRIL 24, 2023

After Walgreens upped its ownership stake in the primary-care company VillageMD from 30 to 63 percent and then announced plans to operate 1,000 clinics by 2027, the writing was on the wall: to stay competitive and manage costs in CVS’ newly integrated Aetna plan, CVS could benefit by making a larger bid for primary care of its own.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

Clarivate

OCTOBER 25, 2023

The dearth of cancer drugs (only blood cancer drug Imbruvica made this first list) stems from CMS only pursuing negotiations for Part D drugs in 2026 and 2027, then expanding to Part B drugs in 2028. exclusions exist for orphan drug designation and biosimilar competition ).

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

Pharmaceutical Technology

JUNE 21, 2023

So far, Empress claims to have generated 15 drug leads across multiple indications. The company claims that timelines from DNA analysis to generating active drug leads “can be measured in months”. Analysts forecast the biologics market to be worth $120 billion more than small molecules by 2027.

Leads 52

Leads Prospecting Pharmaceutical Marketing 52

Pharmaceutical Technology

FEBRUARY 6, 2023

Leading up to 2023, experts have said a company’s financial wellbeing may depend on its economic position when the market shifted. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

Marketing 59

Marketing Pharmaceutical FDA Prospecting 59

Spotio

JULY 5, 2023

billion by 2027—a 48% jump from where the industry was last year, in 2022. Your value proposition should be something like, “We offer customers the peace of mind they crave at a lower price point than the competition.” The question can lead into your story, but the point is to get your prospect to participate.

Sales 40

Sales Prospecting Sales pitches Leads 40

Evolve Your Success

OCTOBER 31, 2023

It’s very competitive. By 2027, they are projected to be about $10 billion. Honestly, because it’s temporary, when we get ready to take out the temporary leads, some of the patients are like, “I don’t want that removed.” Medical sale is a lot more volatile. I made it all the way to my very last interview.

Engineering 130

Engineering Sales Medical sales Medical 130

Impetus Digital

MARCH 15, 2024

In 2022, global spending on cancer medicines was approximately 196 billion USD, and this number is forecasted to reach $375 billion by 2027. Increased competition and evolving standard of care New competitors are entering the market at a rapid pace, and competition is intensifying. However, with rapid growth comes growing pains.

Recruitment 78

Recruitment Healthcare Provider Patients Healthcare 78

Medico Reach

FEBRUARY 8, 2023

AI can lead to faster research, combining and extracting data into usable formats, making clinical trials more efficient and saving time. billion by 2027. Global personalized medicine market forecast for the year 2027: Source The leading pharma firms are designing revolutionary, custom-made treatment methods.

Pharma 52

Pharma Medicine Marketing Prospecting 52

pharmaphorum

JANUARY 16, 2023

This is definitely not because all unmet need is addressed: the WHO reports that the three leading causes of death globally, and growing, are ischaemic heart disease, stroke, and chronic obstructive pulmonary disease. Alzheimer’s is currently the seventh-leading cause of death globally and growing fast. About the author.

FDA 98

FDA Healthcare Healthcare Medicine 98